K. A. Kammaev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
K. A. Kammaev has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- A. A. Petrovskaya
Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - A. A. Ramazanova
Sechenov University
2 shared publications - Dmitry D. Procenko
Sechenov First Moscow State Medical University, Moscow, Russia
2 shared publications - L. R. Shakarova
Sechenov University
2 shared publications - Marina Y. Krylova
Sechenov University
2 shared publications - Tatiana V. Khorobryh
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by IRBIS in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
- Vol. 19 (3) , 591-600
COVID-19-associated coagulopathy and its role in gastroduodenal ulceration
Background. COVID-19-associated coagulopathy is a major manifestation of severe SARS-CoV-2 infection and is characterized by hypercoagulability, endothelial dysfunction, marked systemic inflammation, and microvascular dysfunction. Despite extensive research on hemostatic abnormalities in COVID-19, the role of COVID-19-associated coagulopathy in gastroduodenal ulcerative lesions complicated by gastrointestinal ulceration and gastrointestinal bleeding remains poorly understood. Objective: To characterize COVID-19-associated coagulopathy in patients with gastroduodenal bleeding and determine the relationships between laboratory hemostatic parameters, the severity of lung involvement, hypoxemia, and the endoscopic characteristics of gastroduodenal ulceration. Material and methods. This retrospective study included 72 patients with COVID-19 pneumonia complicated by gastroduodenal bleeding. The analysis included parameters of primary and secondary hemostasis, markers of systemic inflammation, the extent of lung involvement on computed tomography, oxygen saturation, and the morphological characteristics of the ulcers. Correlation and logistic regression analyses were performed to identify factors associated with in-hospital mortality. Results. Patients exhibited pronounced COVID-19-associated coagulopathy, with elevated D-dimer and fibrinogen concentrations, increased C-reactive protein levels, and abnormalities of primary hemostasis. The extent of lung involvement and oxygen saturation were significantly associated with the morphological characteristics of the ulcers. Conclusion. In patients with gastroduodenal bleeding, COVID-19-associated coagulopathy is characterized by both hypercoagulability and hypocoagulability in the setting of pronounced systemic inflammation. The extent of gastroduodenal ulceration is associated not only with laboratory manifestations of coagulopathy but also with the severity of lung involvement, hypoxemia, thrombocytopenia, and ulcer morphometry.
- 7 October 2026
- Published by IRBIS in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
- Vol. 19 (3) , 591-600
Open AccessCOVID-19-associated coagulopathy and its role in gastroduodenal ulceration
Background. COVID-19-associated coagulopathy is a major manifestation of severe SARS-CoV-2 infection and is characterized by hypercoagulability, endothelial dysfunction, marked systemic inflammation, and microvascular dysfunction. Despite extensive research on hemostatic abnormalities in COVID-19, the role of COVID-19-associated coagulopathy in gastroduodenal ulcerative lesions complicated by gastrointestinal ulceration and gastrointestinal bleeding remains poorly understood. Objective: To characterize COVID-19-associated coagulopathy in patients with gastroduodenal bleeding and determine the relationships between laboratory hemostatic parameters, the severity of lung involvement, hypoxemia, and the endoscopic characteristics of gastroduodenal ulceration. Material and methods. This retrospective study included 72 patients with COVID-19 pneumonia complicated by gastroduodenal bleeding. The analysis included parameters of primary and secondary hemostasis, markers of systemic inflammation, the extent of lung involvement on computed tomography, oxygen saturation, and the morphological characteristics of the ulcers. Correlation and logistic regression analyses were performed to identify factors associated with in-hospital mortality. Results. Patients exhibited pronounced COVID-19-associated coagulopathy, with elevated D-dimer and fibrinogen concentrations, increased C-reactive protein levels, and abnormalities of primary hemostasis. The extent of lung involvement and oxygen saturation were significantly associated with the morphological characteristics of the ulcers. Conclusion. In patients with gastroduodenal bleeding, COVID-19-associated coagulopathy is characterized by both hypercoagulability and hypocoagulability in the setting of pronounced systemic inflammation. The extent of gastroduodenal ulceration is associated not only with laboratory manifestations of coagulopathy but also with the severity of lung involvement, hypoxemia, thrombocytopenia, and ulcer morphometry.
- Open Access
- 22 April 2026
- Published by LLC Global Media Technology in Filin’s Clinical endoscopy
- Vol. 68 (1) , 27-30
Endoscopic combined removal of tubulovillous tumor of the descending duodenum
Duodenal tumors (duodenal tumors) are rare neoplasms of the gastrointestinal tract and are characterized by significant clinical and pathological heterogeneity. Depending on the phenotype of mucin, intestinal and gastric types of tumor lesions are distinguished, differing in localization, risks of submucosal invasion and lymphogenic metastasis. The most common malignant neoplasm of the duodenum is adenocarcinoma, with tumors predominantly localized in the descending intestine. The choice of therapeutic tactics depends on the size of the formation, the depth of invasion and the involvement of vascular structures, while endoscopic removal methods are widely used in the early stages of the disease. Objective: to demonstrate the possibilities of a combined endoscopic approach (EMR and ESD) for the removal of a nonampular tubulo-villous tumor of the descending part of the duodenum. Materials and methods: a clinical case of a 67-year-old patient with epithelial formation of the descending part of the duodenum up to 30 mm in size, revealed by esophagogastroduodenoscopy, is presented. According to the radiation examination methods, no signs of transmural growth were detected. Initially, submucosal dissection was performed, complicated by intraoperative bleeding, and therefore the tactics were changed to endoscopic resection of the mucous membrane. Results: The tumor was removed fragmentarily within the unchanged mucous membrane. The removal was accompanied by active bleeding. Hemostasis was successfully achieved using coagulation, local administration of epinephrine, and systemic hemostatic therapy. According to the pathological and anatomical examination, tubulo-villous adenoma with foci of severe epithelial dysplasia was diagnosed. No complications were noted in the postoperative period, and control endoscopic examinations revealed complete epithelialization of the resection area.
- 22 April 2026
- Published by LLC Global Media Technology in Filin’s Clinical endoscopy
- Vol. 68 (1) , 27-30
Open AccessEndoscopic combined removal of tubulovillous tumor of the descending duodenum
Duodenal tumors (duodenal tumors) are rare neoplasms of the gastrointestinal tract and are characterized by significant clinical and pathological heterogeneity. Depending on the phenotype of mucin, intestinal and gastric types of tumor lesions are distinguished, differing in localization, risks of submucosal invasion and lymphogenic metastasis. The most common malignant neoplasm of the duodenum is adenocarcinoma, with tumors predominantly localized in the descending intestine. The choice of therapeutic tactics depends on the size of the formation, the depth of invasion and the involvement of vascular structures, while endoscopic removal methods are widely used in the early stages of the disease. Objective: to demonstrate the possibilities of a combined endoscopic approach (EMR and ESD) for the removal of a nonampular tubulo-villous tumor of the descending part of the duodenum. Materials and methods: a clinical case of a 67-year-old patient with epithelial formation of the descending part of the duodenum up to 30 mm in size, revealed by esophagogastroduodenoscopy, is presented. According to the radiation examination methods, no signs of transmural growth were detected. Initially, submucosal dissection was performed, complicated by intraoperative bleeding, and therefore the tactics were changed to endoscopic resection of the mucous membrane. Results: The tumor was removed fragmentarily within the unchanged mucous membrane. The removal was accompanied by active bleeding. Hemostasis was successfully achieved using coagulation, local administration of epinephrine, and systemic hemostatic therapy. According to the pathological and anatomical examination, tubulo-villous adenoma with foci of severe epithelial dysplasia was diagnosed. No complications were noted in the postoperative period, and control endoscopic examinations revealed complete epithelialization of the resection area.
- 20 February 2026
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 15 (1)
A pathomorphological complete response to neoadjuvant chemotherapy with carboplatin plus paclitaxel in stage IIIA central squamous cell carcinoma of the lung
The article presents a rare clinical case of examination and treatment of a patient with stage IIIA lung squamous cell carcinoma. After neoadjuvant chemotherapy using the standard regimen of paclitaxel-carboplatin (6 injections), a complete pathomorphological response was achieved based on the results of histological and immunohistochemical examination of the postoperative material. During 12 months of follow-up, no recurrences were observed. In light of the results obtained, the issue of the potential benefits of omitting the surgical treatment stage after achieving a complete pathomorphological response to neoadjuvant chemotherapy is raised. Further prospective studies are needed to confirm these conclusions.
- 20 February 2026
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 15 (1)
A pathomorphological complete response to neoadjuvant chemotherapy with carboplatin plus paclitaxel in stage IIIA central squamous cell carcinoma of the lung
The article presents a rare clinical case of examination and treatment of a patient with stage IIIA lung squamous cell carcinoma. After neoadjuvant chemotherapy using the standard regimen of paclitaxel-carboplatin (6 injections), a complete pathomorphological response was achieved based on the results of histological and immunohistochemical examination of the postoperative material. During 12 months of follow-up, no recurrences were observed. In light of the results obtained, the issue of the potential benefits of omitting the surgical treatment stage after achieving a complete pathomorphological response to neoadjuvant chemotherapy is raised. Further prospective studies are needed to confirm these conclusions.
- Open Access
- 17 May 2025
- Published by Immanuel Kant Baltic Federal University in Surgical Practice
- No. 1,p. 12-28
COVID-associated pathomorphological changes in the gastric mucosa during gastrointestinal bleeding
Aim. Analysis of morphological changes in the mucous membrane of the gastrointestinal tract that developed against the background of COVID-19-associated pneumonia, accompanied by bleeding.Methods. The study included 72 cases of erosive and ulcerative gastroduodenal bleeding with complicated Covid-pneumonia. The patients were treated at the University Clinical Hospital No. 4 of Sechenov Moscow State Medical University (Sechenov University) from April 2020 to March 2022.Results. Morphological examination of biopsies from the gastrointestinal tract has provided irrefutable evidence of both direct and indirect effects of the SARS-CoV2 virus on cells of the gastrointestinal mucosa.Conclusion. The gastric mucosa in COVID-19 patients is exposed to the virus, which leads to erosive and ulcerative changes in it, leading to bleeding. This is simultaneously facilitated by anticoagulant and anti-inflammatory therapy given to such patients. These complications must be anticipated and prevented in a timely manner.
- 17 May 2025
- Published by Immanuel Kant Baltic Federal University in Surgical Practice
- No. 1,p. 12-28
Open AccessCOVID-associated pathomorphological changes in the gastric mucosa during gastrointestinal bleeding
Aim. Analysis of morphological changes in the mucous membrane of the gastrointestinal tract that developed against the background of COVID-19-associated pneumonia, accompanied by bleeding.Methods. The study included 72 cases of erosive and ulcerative gastroduodenal bleeding with complicated Covid-pneumonia. The patients were treated at the University Clinical Hospital No. 4 of Sechenov Moscow State Medical University (Sechenov University) from April 2020 to March 2022.Results. Morphological examination of biopsies from the gastrointestinal tract has provided irrefutable evidence of both direct and indirect effects of the SARS-CoV2 virus on cells of the gastrointestinal mucosa.Conclusion. The gastric mucosa in COVID-19 patients is exposed to the virus, which leads to erosive and ulcerative changes in it, leading to bleeding. This is simultaneously facilitated by anticoagulant and anti-inflammatory therapy given to such patients. These complications must be anticipated and prevented in a timely manner.
- Open Access
- 22 October 2024
- Published by LLC Global Media Technology in Filin’s Clinical endoscopy
- Vol. 66 (3) , 62-65
Non-small cell lung carcinoma. Clinical case
In 2020, 2.2 million new cases of lung cancer were reported. The main form of lung cancer is non-small cell carcinoma (85%). Non-small cell lung cancer has 3 subtypes: adenocarcinoma, large cell and squamous cell carcinoma. Squamous cell lung cancer occurs in 20-40% of all lung cancers. Squamous cell lung cancer is associated with an unfavorable outcome. 5-year survival rate not exceeding 18%.
- 22 October 2024
- Published by LLC Global Media Technology in Filin’s Clinical endoscopy
- Vol. 66 (3) , 62-65
Open AccessNon-small cell lung carcinoma. Clinical case
In 2020, 2.2 million new cases of lung cancer were reported. The main form of lung cancer is non-small cell carcinoma (85%). Non-small cell lung cancer has 3 subtypes: adenocarcinoma, large cell and squamous cell carcinoma. Squamous cell lung cancer occurs in 20-40% of all lung cancers. Squamous cell lung cancer is associated with an unfavorable outcome. 5-year survival rate not exceeding 18%.